As of 2025-09-17, the Relative Valuation of Reneo Pharmaceuticals Inc (RPHM) is (12.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of Reneo Pharmaceuticals Inc based on Relative Valuation is -792.2%.
The range of the Relative Valuation is (12.97) - (12.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 13.8x | 13.8x |
| Forward P/E multiples | 12.5x - 13.3x | 12.9x |
| Fair Price | (12.97) - (12.59) | (12.60) |
| Upside | -812.7% - -791.9% | -792.2% |
| Date | P/E |